Small bowel intramural hematoma secondary to abdominal massage

Chen, Hsin-Ling; Wu, Chieh‐Shan; Lin, Aming Chor-Ming

doi:10.1016/j.ajem.2012.11.020

Cited by 7 publications

(12 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Abdominal massages with lifestyle advice versus lifestyle advice alone were evaluated in 1 low‐quality, negative RCT . Because there were significant signals in both arms, the conclusions are “ insufficient evidence ” and “ investigational .” Although abdominal massages should not have AEs, there have been rare reports of potentially fatal complications with abdominal massages for the treatment of constipation in non‐PD patients such as volvulus, small bowel intramural hematoma, or peripheral embolization . Safety was not assessed in this study; therefore, there is “ insufficient evidence” to conclude on the safety of abdominal massage in PD.…”

Section: Results and Conclusionmentioning

confidence: 95%

“…Although abdominal massages should not have AEs, 108 there have been rare reports of potentially fatal complications with abdominal massages for the treatment of constipation in non-PD patients such as volvulus, small bowel intramural hematoma, or peripheral embolization. 105,109,110 Safety was not assessed in this study; therefore, there is "insufficient evidence" to conclude on the safety of abdominal massage in PD.…”

Section: T R E a T M E N T O F T H E N O N M O T O R S Y M P T O M S mentioning

confidence: 98%

“…A total of 3 new studies 12,39,40 were included for the treatment of gastrointestinal dysfunction in PD, and trials not fulfilling the inclusion criteria for review were excluded. 53,56,105 See Table 8 for recommendations.…”

Section: New Conclusionmentioning

confidence: 99%

See 2 more Smart Citations

Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

et al. 2019

View full text Add to dashboard Cite

Objective To update evidence‐based medicine recommendations for treating nonmotor symptoms in Parkinson's disease (PD). Background The International Parkinson and Movement Disorder Society Evidence‐Based Medicine Committee's recommendations for treatments of PD were first published in 2002, updated in 2011, and now updated again through December 31, 2016. Methods Level I studies testing pharmacological, surgical, or nonpharmacological interventions for the treatment of nonmotor symptoms in PD were reviewed. Criteria for inclusion and quality scoring were as previously reported. The disorders covered were a range of neuropsychiatric symptoms, autonomic dysfunction, disorders of sleep and wakefulness, pain, fatigue, impaired olfaction, and ophthalmologic dysfunction. Clinical efficacy, implications for clinical practice, and safety conclusions are reported. Results A total of 37 new studies qualified for review. There were no randomized controlled trials that met inclusion criteria for the treatment of anxiety disorders, rapid eye movement sleep behavior disorder, excessive sweating, impaired olfaction, or ophthalmologic dysfunction. We identified clinically useful or possibly useful interventions for the treatment of depression, apathy, impulse control and related disorders, dementia, psychosis, insomnia, daytime sleepiness, drooling, orthostatic hypotension, gastrointestinal dysfunction, urinary dysfunction, erectile dysfunction, fatigue, and pain. There were no clinically useful interventions identified to treat non‐dementia‐level cognitive impairment. Conclusions The evidence base for treating a range of nonmotor symptoms in PD has grown substantially in recent years. However, treatment options overall remain limited given the high prevalence and adverse impact of these disorders, so the development and testing of new treatments for nonmotor symptoms in PD remains a top priority. © 2019 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

show abstract

Section: Results and Conclusionmentioning

confidence: 95%

Section: T R E a T M E N T O F T H E N O N M O T O R S Y M P T O M S mentioning

confidence: 98%

See 1 more Smart Citation

Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

et al. 2019

View full text Add to dashboard Cite

show abstract

“…The several subtypes of JHS are categorized by the nature of the hemorrhage: i) Traumatic; ii) Emetogenic; iii) Abnormal hemostasis-related; iv) Aorta-related; and v) Spontaneous [19][20][21][22][23][24][25]. In particular, spontaneous submucosal hematoma of the jejunum is further sub-classified into factors that increase the tendency of bleeding such as drugs or an underlying acute or chronic disease [1,3,10,12,22,[26][27][28][29][30].…”

Section: Discussionmentioning

confidence: 99%

“…JHS is more commonly seen in middle-aged patients, with a slight predominance in females. The clinical stages of JHS manifestation are evaluated according to the degree of luminal involvement [25][26][27][28][29][30]. Stage I and Stage II are characterized by isolated hematoma and hematoma with surrounding tissue edema, respectively.…”

Section: Discussionmentioning

confidence: 99%

Complicated Gastric Ulcer and Jejunal Hematoma with Concomitant Warfarin Use: Analytical and Biomedical Case Study Report

Samaha¹,

Hatoum²,

Matar³

et al. 2013

AJMBR

View full text Add to dashboard Cite

Intramural hematoma is commonly known as a hematoma that occurs in the wall of a structure, such as the bowel or bladder, usually resulting from trauma or, in rare situations, excessive anticoagulation. In particular, intramural gastrointestinal hematoma is part of a spectrum of gastrointestinal injuries. Vomiting and straining, endoscopic procedures, and bleeding disorders are essentially among the most common predisposing factors. However, it can also be an unusual complication of anticoagulation and/or thrombolysis therapy. The most common symptoms are retrosternal chest pain, dysphagia, and hematemesis. Intramural bowel wall hematoma is an often forgotten, rare clinical entity that may pose considerable diagnostic dilemma. Therefore, it is conspicuously imperative to diagnose this condition promptly and correctly in order to avoid unnecessary surgical intervention. In this rare presented case report, a 51-year-old woman having mitral valve prothesis and mild heart failure under warfarin wasadmitted to the renowned Sahel General Hospital in Beirut in November of 2006 with massive upper gastrointestinal bleeding that was subsequently controlled by endoscopic sclerotherapy and medical management. About 12 h later, the aforementioned patientsuffered a severe abdominal pain accompanied by a steep dropping in the hematocrit level. Moreover, an abdominal computed tomography scan showed thick jejunal hematoma of approximately 70 cm in length that was handled surgically. The patient had been incessantly observed for about 7 days,andsubsequently discharged with therapeutic international normalized ratio(INR).

show abstract

Abdominal massage: A review of clinical and experimental studies from 1990 to 2021

Wang¹,

Zhang²,

Sun³

et al. 2022

Complementary Therapies in Medicine

View full text Add to dashboard Cite

Small bowel intramural hematoma secondary to abdominal massage

Cited by 7 publications

References 4 publications

Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

Complicated Gastric Ulcer and Jejunal Hematoma with Concomitant Warfarin Use: Analytical and Biomedical Case Study Report

Abdominal massage: A review of clinical and experimental studies from 1990 to 2021

Contact Info

Product

Resources

About